Word: buyouts
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...Bank of America Loan losses: BofA's buyout of mortgage broker Countrywide means the bank has $400 billion in home loans outstanding - more than its competitors. Worse, Countrywide, by nearly all accounts, had shockingly low lending standards. Chalk up a higher-than-average $40 billion in losses there. On top of that, BofA has made $87 billion in loans to commercial real estate developers. Roubini predicts 17% of those loans will go bad as developers hit the skids. For BofA, that's $15 billion more in losses. Toss in $55 billion in commercial- and consumer-loan losses...
...crisis since the Great Depression” and follows months of University deliberation over its operating expenses and capital projects. Harvard has asked schools to institute a salary freeze for faculty and non-union staff and recently announced that it would offer some staff over the age of 55 buyout packages in an effort to reduce costs...
...Bank of America (BAC) and Citigroup (C). Some of Citi's most prominent members have left, probably not entirely of their own volition. The board at B of A has been savagely attacked over the last several weeks because it did not insist on better due diligence in the buyout of Merrill Lynch and for allowing large bonuses to be paid to employees after the firm had taken TARP money...
...facilitate a sale, SEBI is planning to relax the rules governing corporate buyouts. Currently, any group wanting to acquire a minimum 15% stake in a company must make an open offer to all shareholders based on a 26-week average share price. SEBI wants to waive this requirement to enable more realistic pricing of Satyam's shares, which plunged by more than 70% after the scandal broke and now trade at about $1.27 a share. Satyam's government-appointed board are discussing buyout options this week, but a sale cannot be completed until its accounts are restated, a process that...
...Pfizer is now in merger negotiations with its one of its big pharm peers, Wyeth (WYE). The transaction would be done as a $60 billion buyout of Wyeth. According to The Wall Street Journal, "If completed, a deal could create billions in cost savings through the combination of back-office operations, research and development, sales and manufacturing...